Over the last three years, the FDA has approved six new hemophilia drugs, including three gene therapies. Into this crowded treatment landscape comes another new medicine as the FDA has signed off ...

Hemophilia is a rare bleeding disorder characterized by low levels of proteins called “clotting factors.” Hemophilia is an inherited blood disorder in which your blood does not clot properly ...

Hemophilia A is characterized by FVIII deficiency, leading to joint bleeds and chronic pain despite prophylactic therapy. Treatment options vary in sustaining FVIII levels, with gene therapy and ...